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Summary
We performed variance component-based linkage analysis in four samples (two of non-Hispanic European-
Americans from Rochester, MN; African-Americans from Jackson, MS; and Mexican-Americans from Starr County,
TX) to identify chromosomal regions containing genes influencing plasma apolipoprotein E (apoE) levels. The
APOE gene region on chromosome (chr) 19 was identified with a LOD ≥ 2.00 in both samples from Rochester
and the sample from Jackson. Adjustment of apoE levels for differences among means of genotypes defined by the
APOE ε2/3/4 alleles reduced evidence of linkage, indicating that the APOE gene was responsible for the majority
of the linkage signal. In stratified linkage analyses, there was a LOD of 1.70 in the Starr County sibships with average
total cholesterol (TC) above the median level for all sibships in that population. Adjustment for APOE genotype
did not remove this LOD score, suggesting a second gene in this region may influence apoE variation. Evidence of
linkage (LOD = 3.32) on chr 17 was observed in the Starr County sibships with average TC below the median.
Inter-individual variation in plasma apoE level may be influenced by variations in the structural gene, and at least
one other gene whose effects differ among populations and are dependent on the influence of unmeasured genetic
and environmental factors indexed by correlated measures of lipid metabolism.
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Introduction
In blood, apolipoprotein E (apoE) plays a regula-
tory role in the receptor-mediated metabolism of risk
factors for coronary artery disease, including triglyc-
eride (TG)-rich chylomicrons, low-density lipoprotein
(LDL), and high-density lipoprotein (HDL) particles
(Davignon et al. 1988, 1993; Mahaney et al. 1995;
Mahley et al. 2000). Our previously published variance
components-based linkage analysis validated the influ-
ence of theAPOE structural gene on inter-individual
variation in plasma apoE levels, but failed to provide
∗Corresponding author: Dr. Kathy L.E. Klos University of Texas
Health Science Center at Houston School of Public Health Hu-
man Genetics Center P.O. Box 20186 Houston, TX 77225 USA.
Telephone: (713) 500-9914; Fax: (713) 500-0900. Email: kk-
los@sph.uth.tmc.edu
significant evidence for additional genes (Klos et al.
2001). In the study presented here we have expanded ge-
netic linkage analyses to identify genomic regions that
influence plasma apoE level in three additional sam-
ples (an additional sample of non-Hispanic European-
Americans from Rochester, MN; a sample of African-
Americans from Jackson, MS; and a sample of Mexican-
Americans from Starr County, TX). We found evidence
of linkage in the region of the APOE structural gene
(chromosome 19q) in all samples except Starr County,
which was unique in that sibships were ascertained by
a proband having type II diabetes. Tentative to sugges-
tive evidence of linkage specific to a single sample was
observed at six regions of the genome.
The biological reality of the complex multifactorial
etiology of quantitative traits such as plasma apoE sug-
gests that many genes may interact with each other, and
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with environmental factors, resulting in a particular gene
contributing to trait variation in some families but not
others (Sing et al. 1996, 2003; Greenspan, 2001). The
extent to which populations-of-inference are homoge-
neous for the relative frequencies of causal genetic and
environmental agents will also influence the probabil-
ity of replicating linkage evidence. This potential for
context-dependency, along with the unique lack of ev-
idence for linkage in the Starr County sample at the
well-studied APOE gene region, led us to examine evi-
dence of linkage within particular genetic and environ-
mental contexts of this sample, as indexed by sibship
average total cholesterol (TC) level. Individuals with
type II diabetes have an altered lipid profile, implying
that strata of pedigrees indexed by TC may have greater
homogeneity of interacting genetic and environmental
effects, resulting in stronger single gene-phenotype rela-
tionships. Stratified linkage analyses of the Starr County
sample revealed evidence of context-dependency at the
APOE gene region on chromosome (chr) 19. Analyses
of all four samples stratified by TC revealed significant
evidence of linkage on chr 17 in the low TC strata of
Starr County, suggesting the presence of an additional
gene or genes whose effects on plasma apoE levels were
undetected in the unstratified analyses.
METHODS
Sample and Laboratory Methods
The four samples examined in this study came from
two different collaborative efforts – the Rochester Fam-
ily Heart Study (RFHS) and the Genetic Epidemiol-
ogy Network of Arteriopathy (GENOA). As part of
the RFHS, multi-generation pedigrees were ascertained
without regard for health through households with two
or more children enrolled in the primary and secondary
schools of Rochester, MN. Sampling details, the clinic
examination protocol and baseline characteristics have
been described by Moll et al. (1989) and Turner et al.
(1989). Genotype data for 372 highly polymorphic mi-
crosatellite marker loci located on the 22 human auto-
somes was obtained for 1484 individuals (779 females
and 705 males) in 232 multi-generation pedigrees. Me-
dian distance between markers was 8.3 centiMorgans
(cM). Genotyping methods and laboratory analyses are
described in detail elsewhere (Klos et al. 2001). Plasma
apoE level was measured by radioimmunoassay (Kottke
et al. 1991).
As part of the GENOA study, sibships from Jackson,
MS and Rochester, MN were recruited if they con-
tained at least two full siblings with essential hyperten-
sion, clinically diagnosed before the age of 60 years.
Sibships from Starr County, TX were recruited if they
contained at least 2 full siblings with type II diabetes.
Sampling details, the clinic and laboratory protocols and
baseline characteristics have been described by Daniels
et al. (2004). Genotyping of 373 highly polymorphic
microsatellite marker loci located on the 22 human au-
tosomes (from CHLC/Weber screening set 9.0) was
performed at the Mammalian Genotyping Center of
the Marshfield Medical Research Foundation. Median
distance between markers was 8.5 cM. Genotype and
phenotype data were obtained for 1696 non-Hispanic
African-Americans (1166 females and 530 males) in
592 sibships from Jackson (GENOA-Jackson), for 1415
non-Hispanic European-Americans (770 females and
645 males) in 505 sibships from Rochester (GENOA-
Rochester), and for 1651 Mexican-American individ-
uals (974 females and 677 males) in 418 sibships from
Starr County (GENOA-Starr County). There were 369
half-sib and 1781 full-sib pairs in GENOA-Jackson, 50
half-sib and 1716 full-sib pairs in GENOA-Rochester,
and 118 half-sib and 3022 full-sib pairs in GENOA-Starr
County. Forty-six individuals (in 36 sibships) sampled as
part of GENOA-Rochester were also sampled as part of
the RFHS. Details of the marker genotyping and valida-
tion are reported elsewhere (Kardia et al. 2003). Plasma
apoE level was measured by radioimmunoassay (Kottke
et al. 1991).
Homogeneity of quantitative trait variances among
samples was evaluated using Levene’s test (Levene,
1960). Differences among sample means were evaluated
by the one-way analysis of variance (Sokal & Rohlf,
1998). Where variances were unequal, Welch’s modi-
fied F statistic (Welch, 1951) was used in assessing signif-
icance. Equivalent conclusions were obtained using the
Welch technique and the standard analysis of variance.
The Boerwinkle & Sing (1986) bias-corrected estima-
tor of genetic variance was used to measure the percent
of plasma apoE variance attributable to deviations of
APOE genotype means from the population mean. An
158 Annals of Human Genetics (2005) 69,157–167 C© University College London 2005
Linkage for plasma apoE
alpha level of 0.05 was used to determine statistical sig-
nificance, except where otherwise noted.
Linkage Analysis
Prior to linkage analysis, a linear regression model con-
taining age, age2, age3, height, height2, height3, weight,
weight2, weight3, and BMI was fitted to plasma apoE
level within gender and, after adjustment, the sample
grand mean was added to the residuals. The methods
used for linkage analysis are described in detail in Klos
et al. (2001). In brief, using the computer program SO-
LAR (Almasy & Blangero, 1998), we fitted a linear
mixed model to the age, height, weight and BMI ad-
justed data such that for each pedigree the phenotypic
variance-covariance matrix (Ω) could be written:





where Φ is a matrix of the proportion of alleles shared
identical by descent (IBD) at a point in the genome,
σ 2QTL represents the portion of the phenotypic variance
about the trait mean attributable to the contribution of
a quantitative trait locus (QTL), Π is a matrix of the
expected proportion of alleles shared IBD for pairs of
relatives, σ 2R is the variance attributable to familial ge-
netic and unspecified shared environmental effects, I is
an identity matrix, and σ 2E is the variance attributable to
measurement errors and environmental effects unique to
the individual. Due to the existence of large pedigrees in
the RFHS (pedigree size ranged from 2 to 31 individu-
als), and to maintain consistency of analysis across sam-
ples, multipoint estimates of IBD were obtained from
SOLAR as a weighted average of the IBD at each indi-
vidual marker. Linkage analyses based on the IBD ap-
proximation method employed by SOLAR have lower
power than those based on multipoint IBDs computed
by a Markov chain Monte Carlo approach (Goring et al.
2002). However, the SOLAR method is more robust to
genotyping error and to double recombination events.
LOD scores were calculated as the difference between
the maximum of the log10 likelihoods of the full model,
above, and of the reduced model in which σ 2QTL was
constrained to equal zero (Fulker et al. 1995; Almasy
& Blangero, 1998). Likelihood calculations were per-
formed under the assumption of an underlying multi-
variate t-distribution that allows for robust estimates of
variance components in the presence of deviations from
a normal distribution (Hopper, 1988; Lange et al. 1988,
1989).
In the presence of genetic heterogeneity, sample strat-
ification may improve the power to detect linkage pro-
vided there is reduced heterogeneity within strata com-
pared to heterogeneity among strata (Leal & Ott, 2000).
However, identification of an appropriate stratification
variable is problematic. We hypothesize that the genetic
influences on plasma apoE variation may differ among
groups defined by different plasma lipid profiles. Be-
cause a biologically relevant measure of the difference
in the genetic and environmental influences on plasma
apoE levels between dyslipidaemic and normolipidemic
individuals is not known, sample stratification in this
case was based on the pedigree average TC level. The
average TC level of all members was calculated for each
pedigree; pedigrees were ranked by average TC, and
then divided at the median into two strata.
We have used a LOD score threshold of ≥3.00 to in-
dicate statistically significant evidence of linkage, a LOD
of ≥2.00 and <3.00 as suggestive, and a LOD ≥ 1.30
and <2.00 as tentative evidence of linkage (Lander &
Kruglyak, 1995; Morton, 1998).
In order to test the hypothesis that the LOD score
peaks on chr 19 were due to the influence of the APOE
structural gene, the APOE ε2/3/4 polymorphism was
genotyped in the individuals from all four samples, and
plasma ApoE levels were adjusted for APOE genotype
means (after previous adjustments for age, height, weight
and BMI). This method removes plasma apoE varia-
tion associated with the fixed, marginal effects of APOE
ε2/3/4 genotypes. Linkage analysis was performed on
plasma ApoE levels adjusted for APOE genotype as de-
scribed above. This method should remove evidence of
linkage on chr 19 due to variation in the APOE ε2/3/4
polymorphism, and may increase evidence of linkage
at other QTLs by increasing the proportion of vari-
ance that they explain. In a second method, the APOE
ε2/3/4 polymorphism was added to the marker list at 70
cM on chr 19. Multipoint IBD estimates were obtained,
incorporating the APOE ε2/3/4 polymorphism infor-
mation, and variance component-based linkage anal-
ysis was performed on plasma apoE adjusted for age,
height, weight and BMI. In this method, the propor-
tion of variance attributed to IBD sharing for the APOE
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Table 1 Characteristics of 1484 individuals from the Rochester Family Heart Study (RFHS), of 1696 individuals from the Genetic
Epidemiology Network of Arteriopathy (GENOA) - Jackson, of 1415 individuals from GENOA-Rochester and of 1650 individuals
from GENOA-Starr County
RFHS GENOA-Jackson GENOA-Rochester GENOA-Starr County
N 1484 1696 1415 1651
% Female 52.5 68.8 54.4 59.0
Pedigrees 232 592 505 418
Age 37.7±24.1† 57±10.3 55.9±11.0 55.2±12.1
Height (cm) 163.8±14.8 168.7±8.8 168.7±9.3 162.9±9.2
Weight (kg) 64.7±20.2 87.8±18.7 86.7±19.9 81.8±17.3
Systolic BP 114.0±22.3 136.4±22.8 133.9±17.1 128.5±19.9
Diastolic BP 63.2±13.3 77.8±12.4 78.6±9.6 73.8±10.1
BMI (kg/m2) 23.6±5.3 30.9±6.6 30.4±6.3 30.8±6.1
TC (mg/dl) 178.5±45.9 205.1±46.9 210.4±38.9 205.4±46.4
ApoE (mg/dl) 5.1± .9 5.3±2.2 5.2±1.7 5.4±2.2
∗Significant differences among samples at an α = 0.05
†Mean ± the standard deviation
ε2/3/4 polymorphism is estimated, and should result in
increased power to detect the APOE gene effect.
Results
Descriptive Statistics
Characteristics of the 1484 RFHS, the 1696 GENOA-
Jackson, the 1415 GENOA-Rochester and the 1651
GENOA-Starr County individuals used in the link-
age analyses are reported in Table 1. Means and vari-
ances differed significantly among samples at the p <
0.001 level for all traits, largely due to the difference
in sampling strategy between the RFHS and GENOA
studies. The multi-generation RFHS pedigrees were
younger (p < 0.0001), less obese (p < 0.0001), and
had lower TC (p < 0.0001), than the average of the
three GENOA samples of sibships. The mean apoE level
of the GENOA-Starr County sample was significantly
higher than the mean of the other three samples pooled
(p = 0.0009). Heritability of plasma ApoE was 0.57 ±
0.07 in GENOA-Jackson, 0.40 ± 0.07 in GENOA-
Rochester, 0.39 ± 0.06 in GENOA-Starr County and
0.62 ± 0.05 in the RFHS. Heritability estimates were
significant at an α = 0.0001 in all cases.
Linkage Analysis
In Figure 1, the multipoint LOD scores from linkage
analyses of all four samples are plotted against map posi-
tion for each chromosome (in cM from the p-terminal).
The highest multipoint LOD scores from analyses of
GENOA-Jackson, GENOA-Rochester and the RFHS
were on chr 19 (LOD = 4.69 at 69 cM, LOD = 2.32 at
74 cM and LOD = 4.20 at 78 cM, respectively). The
peak multipoint LOD score on chr 19 in GENOA-
Starr County was 0.97 at 78 cM. In addition to sig-
nificant evidence of linkage on chr 19, a multipoint
LOD score suggestive of linkage (LOD = 2.23 at 97
cM) was observed on chr 3 in the GENOA-Jackson
sample. Tentative evidence of linkage was observed in
the GENOA-Jackson sample on chr 2 (LOD = 1.65
at 210 cM) and chr 8 (LOD = 1.60 at 67 cM), in the
GENOA-Rochester sample on chr 13 (LOD = 1.44 at
80 cM), in the GENOA-Starr County sample on chr
10 (LOD = 1.68 at 67 cM) and in the RFHS on chr
12 (LOD = 1.50 at 53 cM).
The APOE ε2/3/4 polymorphism accounted for
11% (p < 0.0001), 9% (p < 0.0001), 3% (p = 0.0002)
and 1% (p = 0.0182) of plasma apoE variance in males
of RFHS, GENOA-Jackson, GENOA-Rochester and
GENOA-Starr County, respectively. In females, this
polymorphism accounted for 11% (p < 0.0001), 20%
(p < 0.0001) and 17% (p < 0.0001) of apoE variance
in RFHS, GENOA-Jackson and GENOA-Rochester,
but was not a significant source of variation (0.4%,
p = 0.1170) in GENOA-Starr County. The multipoint
LOD scores on chr 19 from linkage analyses of the
adjusted apoE levels in all four samples are plotted in
Figure 2A. After adjustment for APOE genotype,
the LOD scores decreased in all samples. The high-
est multipoint LOD scores were 1.72 at 71 cM in
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Figure 1 Multipoint LOD score plots for 22 chromosomes from the linkage analyses of plasma apoE
level in pedigrees from the Rochester Family Heart Study (RFHS) and GENOA sibships from Jackson
(GENOA-Jackson), Rochester (GENOA-Rochester) and Starr County (GENOA-Starr County).
GENOA-Jackson, 1.67 at 76 cM in GENOA-
Rochester, and 0.80 at 78 cM in GENOA-Starr County
(LOD scores for unadjusted data were 4.69 at 96 cM,
2.32 at 74 cM and 0.97 at 78 cM, respectively). This
is consistent with previously documented evidence of
a decrease in LOD score from 4.20 at 78 cM to 1.10
at 78 cM in the RFHS5, and indicates that in samples
from Rochester and Jackson, variation in the APOE
gene accounted for the majority of the linkage signal on
chr 19.
Evidence of linkage on chr 3 in GENOA-Jackson re-
mained suggestive after adjustment of plasma apoE lev-
els for APOE ε2/3/4 genotype means (LOD = 2.20
at 170 cM). Tentative evidence of linkage also re-
mained on chr 2, 8, 10 and 13 (not shown). Tenta-
tive evidence of linkage on chr 12 in the RFHS did
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Figure 1 Continued.
not remain after adjustment for APOEgenotype means
(LOD < 1.00).
Linkage analyses with the measured APOE polymor-
phism incorporated into the marker set at 70 cM on chr
19 (using plasma apoE data unadjusted for APOE geno-
type) resulted in higher peak multipoint LOD scores in
all samples except GENOA-Starr County. Inclusion of
the APOE polymorphism resulted in the peak multi-
point LOD scores on chr 19 increasing from 4.20 at
78 cM to 7.19 at 70 cM in the RFHS, from 4.69 at
96 cM to 6.09 at 70 cM in GENOA-Jackson, and from
2.32 at 74 cM to 2.51 at 73 cM in GENOA-Rochester.
The peak multipoint LOD score remained 0.97 at 78 cM
in GENOA-Starr County. The high LOD scores in
GENOA-Jackson and the RFHS provide strong sup-
port for the hypothesis that the APOE structural gene
is a major determinant of plasma apoE levels in these
samples.
Stratified Linkage Analyses
The well-documented context-dependency of the phe-
notypic effects of the APOE gene (Zerba et al. 1996;
Jarvik et al. 1997; Kardia et al. 1998, 1999; Campos et al.
2001; Lussier-Cacan et al. 2002) supports the hypothesis
that the control of plasma apoE level depends on multi-
ple genetic and environmental factors. In GENOA-Starr
County, the peak multipoint LOD score on chr 19 was
below the threshold of tentative evidence of linkage, in-
dicating that the APOE gene may play little or no role in
determining inter-individual variation in plasma apoE
levels, in this particular population, or may influence
plasma apoE levels in some pedigrees but not others.
To evaluate the potential of context-dependent stratified
linkage analysis for detecting heterogeneity of the effects
of the APOE gene, total cholesterol was selected as an
index of the relative level of dyslipidaemia among the
sibships of GENOA-Starr County. On chr 19, a LOD
score of 1.70 at 83 cM (tentative evidence of linkage)
was observed for GENOA-Starr County sibships with
average TC levels above the median (figure 2B). Evalua-
tion of linkage in these sibships incorporating the APOE
ε2/3/4 polymorphism as part of the marker map did
not improve LOD scores (peak LOD on chr 19 = 1.68
at 84 cM). Stratified linkage analyses on chr 19 using
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Figure 2 Multipoint LOD scores from linkage analyses of
plasma apoE level adjusted for APOE ε2/3/4 genotype on
chromosome 19 A) in pedigrees from the Rochester Family
Heart Study (RFHS) and GENOA sibships from Jackson
(GENOA-Jackson), Rochester (GENOA-Rochester) and Starr
County (GENOA-Starr County) and B) in sibships from
GENOA-Starr County with average TC level above the
median.
the plasma apoE levels adjusted for age, height, weight,
BMI and APOE genotype only reduced the peak LOD
score to 1.30 at 83 cM, still tentative evidence of linkage
(figure 2B).
Linkage analyses of all chromosomes were performed
in all samples stratified at the median by sibship or pedi-
gree average TC level. Peak multipoint LOD scores
≥1.30 from the stratified linkage analyses are shown in
Table 2. Statistically significant evidence of linkage on
chr 17 (LOD = 3.32 at 103 cM) was observed in
GENOA-Starr County sibships with TC levels below
the median (Figure 3). In the other three samples, peak
multipoint LOD scores on chr 17 in strata indexed by
pedigree average TC were below the threshold of ten-
tative evidence of linkage (not shown), as were those
of the unstratified analyses of this region (Figure 1). In
contrast to GENOA-Starr County, LOD scores on chr
19 from the stratified analyses of the GENOA-Jackson,
GENOA-Rochester and RFHS samples were consis-
tently lower than those in the unstratified analyses.
Discussion
Evidence of Linkage in the APOE
Gene Region
Our linkage analyses of the APOE gene region docu-
ment the dependency of the APOE gene on the back-
ground genetic and environmental context that varies
among populations, and among pedigrees within a par-
ticular population. Replicated evidence of the influ-
ence of the APOE gene in three out of four sam-
ples is consistent with the many studies of the impact
of this gene on lipid metabolism. As much as 50% of
genotypic variation in plasma apoE level may be at-
tributable to variation in the APOE gene (Boerwinkle &
Utermann, 1988; Neale et al. 2000). Adjusting plasma
apoE for the observed APOE genotypes influenced
the evidence of linkage on chr 19 in all samples.
In GENOA-Jackson and GENOA-Rochester, tenta-
tive evidence of linkage remained after adjustment for
APOE genotype (LOD = 1.72 and 1.67, respectively).
Adjustment of plasma apoE levels was made using only
the ε2/3/4 polymorphism, and did not account for the
effects of other functional polymorphisms in the APOE
gene region. The APOE gene is part of a 48 kb cluster
including the APOC1, APOC4 and APOC2 genes, and
two hepatic control regions which influence expression
of all genes in the cluster ( Jong et al. 1999). Variation in
the APOE/C1/C2/C4 gene cluster, outside the APOE
coding region, may also be partially responsible for
inter-individual variation in plasma apoE level in these
samples.
The effect of the APOE gene on plasma apoE level is
not uniform among or within populations. Depending
on the gender and population studied, the APOEgene
region may explain as much as 30%, or as little as 5%
of phenotypic variation in plasma apoE levels(Davignon
et al. 1988; Kaprio et al. 1991; Hsueh et al. 2000; Sten-
gard et al. 2002). The lack of evidence for the contribu-
tion of this gene region in the GENOA-Starr County
sample may indicate an influence of the APOE gene on
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Table 2 Peak multipoint LOD scores
≥1.30 for plasma apoE level from linkage
analyses of the RFHS, GENOA-Jackson,
GENOA-Rochester and GENOA-Starr
County samples stratified at the median
by pedigree average TC level.
Chromosome LOD score Location Sample Strata
2 1.42 179 cM GENOA-Jackson Low TC
3 1.42 213 cM GENOA-Starr County Low TC
6 1.51 0 cM GENOA-Jackson Low TC
6 1.44 30 cM RFHS High TC
7 1.90 137 cM GENOA-Starr County Low TC
12 1.31 36 cM RFHS High TC
15 1.64 122 cM GENOA-Starr County High TC
17 3.32 103 cM GENOA-Starr County Low TC
19 2.29 68 cM GENOA-Jackson Low TC
19 2.49 71 cM GENOA-Jackson High TC
19 3.20 71 cM RFHS Low TC
19 2.10 76 cM GENOA-Rochester Low TC
19 1.70 83 cM GENOA-Starr County High TC
19 1.99 88 cM RFHS High TC
Figure 3 Multipoint LOD scores from the linkage analysis of
plasma apoE on chromosome 17 in GENOA sibships from Starr
County (GENOA-Starr County) with average total cholesterol
(TC) levels below the median.
plasma apoE below the level detectible by linkage analy-
sis. This seems likely in light of our subsequent stratified
analyses.
Within-population context-dependencies of the phe-
notypic effect of the APOE gene on plasma apoE level
have been documented, and include age, smoking and
BMI (Zerba et al. 1996; Jarvik et al. 1997; Lussier-Cacan
et al. 2002). Stratification can provide a means of in-
corporating context-dependency in such a way as to
reveal evidence of linkage not obtained from the full
sample. Leal & Ott (2000) used stratification to improve
the ability to detect linkage in the presence of genetic
heterogeneity among samples of simulated affected-sib-
pairs, where variation at a locus contributed to pheno-
typic variation in some, but not all, sibships. Improved
LOD scores for diastolic and systolic blood pressure
were found by Rice et al. (2000) when pedigrees as-
certained through a highly obese (BMI > 32 kg/m2)
family member were separated from randomly as-
certained pedigrees. Stratified linkage analyses of the
GENOA-Starr County sample indexed by sibship av-
erage TC level provided tentative evidence of linkage
in the region of the APOE gene. However, adjustment
of plasma apoE level for APOE genotype in GENOA-
Starr County sibships with average TC above the me-
dian did not remove evidence of linkage, indicating that
the ε2/3/4 polymorphism was not responsible for the
linkage signal. The context-dependent linkage evidence
on chr 19 in GENOA-Starr County may be due to type
I error, or may indicate the context-dependent influ-
ence of genetic variation other than APOE ε2/3/4 on
plasma apoE levels. Examples in yeast and maize provide
precedents for multiple genes underlying a single QTL
(Steinmetz et al. 2002; Zhang et al. 2003).In GENOA-
Starr County, identification of new linkage evidence on
chr 19, with stratification by TC, serves to emphasize
the importance of context-dependent gene effects in
defining the genetic architecture of a quantitative inter-
mediate risk factor of CAD. Our linkage analyses of the
chr 19 APOE gene region also highlight the difficulties
to be faced as researchers attempt to identify the genes
responsible for a linkage peak.
Evidence of Linkage on Other Chromosomal
Regions
Suggestive evidence of linkage on chr 3 in the unstrati-
fied GENOA-Jackson sample may indicate a gene with
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a weak or context-dependent effect on plasma apoE
level. No obvious candidate genes lie in this region, but
this peak is one cM from the location, identified by Im-
peratore et al. (2000), of tentative evidence of linkage
with a gene(s) influencing TG levels (LOD = 1.77 at
98 cM) in a sample of Pima Indians. Tentative evidence
of linkage in GENOA-Starr County sibships with aver-
age TC below the median (Table 2) was 116 cM from
the GENOA-Jackson peak, and is not likely to repre-
sent the same underlying gene(s). Stratification of the
GENOA-Jackson sample by sibship average TC level
did not improve the LOD score in this region.
With stratification of the GENOA-Starr County
sample by TC, there was significant evidence of link-
age on chr 17 with a gene(s) that may influence plasma
apoE levels in a manner dependent on genetic and en-
vironmental context, at least partially indexed by TC. A
strong candidate, the APOH gene, is located near the
multipoint LOD score peak on chr 17. Variation in the
APOHgene has been associated with variation in plasma
apoE levels in unrelated males from the RFHS (Kaprio
et al. 1991) and may also influence TG, TC and LDL-
C levels in a population-dependent manner (Kamboh
et al. 1996, 1999). To our knowledge, within-population
context-dependency of the APOH gene has not been
investigated. Further study is warranted to investigate
the influence of variation in APOH, or other genes in
this region of chr 17, on variation in plasma apoE levels.
With the exception of chr 19 (Figure 1), and the
possible exception of tentative evidence of linkage on
chr 6 (Table 2), no linkage peak in these stratified or
unstratified analyses of plasma apoE level had a LOD
score ≥1.30 in a second sample. Replicated evidence
of linkage has proven notoriously difficult to procure
in the analysis of complex traits; however, this would
be expected if gene effects are dependent on sample-
specific (or strata-specific) genetic and environmental
contexts. While evidence of linkage on both chr 3 and
17 is supported by evidence from additional linkage
and candidate gene studies, type I error remains a pos-
sibility due to the lack of replication in independent
analyses.
It has been argued that combined analysis of many
samples may be necessary to provide the power to de-
tect genes of small effect in complex traits (Ioannidis
et al. 2001; Lohmueller et al. 2003; Province et al. 2003).
If complex traits are governed by context-dependent
gene effects (which may be quite large in some pedi-
grees), rather than by small invariant effects, then a
meta-analysis will only serve to exacerbate the prob-
lem by burying the signal under an even larger pile of
non-informative pedigrees. This may explain the failure
of some meta-analyses to provide support for previously
identified evidence of linkage in studies of complex traits
such as hypertension and asthma (Province et al. 2003;
Etzel & Guerra, 2002). Our stratified linkage results on
chr 17 and 19 support the expectation that identification
of some genes which influence plasma apoE levels will
require a statistical model which incorporates genetic
and environmental context. We conclude that research
strategies that reflect the biological reality of etiologi-
cal complexity may provide more valuable insights into
the genetic architecture of quantitative traits than studies
that simply test for invariant, universal genetic effects.
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